Endocrine Therapy plus Zoledronic Acid in Premenopausal Breast Cancer

Michael Gnant, Brigitte Mlineritsch, Walter Schippinger, +18

New England Journal of Medicine

Switching of postmenopausal women with endocrine-responsive early breast cancer to anastrozole after 2 years' adjuvant tamoxifen: combined results of ABCSG trial 8 and ARNO 95 trial

R. Jakesz, W. Jonat, Michael Gnant, +10

The Lancet

Breast OncologyMedicinePharmacologyGynecologyAdjuvant Tamoxifen +8

Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 62-month follow-up from the ABCSG-12 randomised trial

Michael Gnant, Brigitte Mlineritsch, Herbert Stoeger, +17

The Lancet Oncology

Zoledronic AcidBreast OncologyOncologyEndocrine-related CancerEndocrine Oncology +8

Predicting distant recurrence in receptor-positive breast cancer patients with limited clinicopathological risk: using the PAM50 Risk of Recurrence score in 1478 postmenopausal patients of the ABCSG-8 trial treated with adjuvant endocrine therapy alone

Michael Gnant, Martin Filipits, Richard Greil, +21

Annals of Oncology

Surgical OncologyBreast OncologyRecurrence ScoreDistant RecurrenceCancer Recurrence +8

Overexpression of hypoxia-inducible factor 1alpha is associated with an unfavorable prognosis in lymph node-positive breast cancer.

Monika Schindl, Sebastian F. Schoppmann, Hellmut Samonigg, +7

PubMed

Extended Adjuvant Therapy With Anastrozole Among Postmenopausal Breast Cancer Patients: Results From the Randomized Austrian Breast and Colorectal Cancer Study Group Trial 6a

R. Jakesz, Richard Greil, Michael Gnant, +11

JNCI Journal of the National Cancer Institute

Zoledronic acid combined with adjuvant endocrine therapy of tamoxifen versus anastrozol plus ovarian function suppression in premenopausal early breast cancer: final analysis of the Austrian Breast and Colorectal Cancer Study Group Trial 12

Michael Gnant, Brigitte Mlineritsch, Herbert Stoeger, +22

Annals of Oncology

Zoledronic AcidBreast OncologyEndocrine OncologyMedicinePharmacology +10

Randomized Adjuvant Trial of Tamoxifen and Goserelin Versus Cyclophosphamide, Methotrexate, and Fluorouracil: Evidence for the Superiority of Treatment With Endocrine Blockade in Premenopausal Patients With Hormone-Responsive Breast Cancer—Austrian Breast and Colorectal Cancer Study Group Trial 5

R. Jakesz, H. Hausmaninger, E. Kubista, +12

Journal of Clinical Oncology

Lumpectomy Plus Tamoxifen or Anastrozole With or Without Whole Breast Irradiation in Women With Favorable Early Breast Cancer

Richard Pötter, Michael Gnant, W. Kwasny, +17

International Journal of Radiation Oncology*Biology*Physics

Surgical OncologyBreast OncologyRadiation TherapyMedicineGynecology +5

Biweekly high-dose gemcitabine alone or in combination with capecitabine in patients with metastatic pancreatic adenocarcinoma: a randomized phase II trial

Werner Scheithauer, B. Schüll, H. Ulrich-Pur, +7

Annals of Oncology

OncologyPancreatic CancerGastrointestinal OncologyMetastatic Pancreatic AdenocarcinomaPharmacotherapy +4